Madde Kullanım Bozuklukları ve Yenidoğan
Referanslar
Sadock BJ, Sadock VA, Ruiz P. Comprehensive textbook of psychiatry: lippincott Williams & wilkins Philadelphia; 2000. ss. 15.
Amerikan Psikiyatri Birliği, Ruhsal Bozuklukların Tanısal ve Sayımsal El kitabı. DSM-V, Tanı Ölçütleri Başvuru Elkitabı. (Ed. Köroğlu E) Ankara: Hekimler Yayın Birliği; 2013. ss. 1002.
Yalnız Dilcen H, Ada G. Madde kötüye kullanımı tespitinde adli ebeler. Adli Ebelik. (Ed. Türkmen H, Tuna Oran N, Hancı H, Tezbasan İY) Ankara: Seçkin Kitabevi; 2023. ss. 287-304. ISBN:978-975-02-8970-5
Orum MH, Kara MZ, Egilmez OB, Ozen ME, Kalenderoglu A. Evaluation of probation implementations of drug users in Adiyaman university training and research hospital: A one-year retrospective study. Med Science. 2018; 7(4): 754-758.
Sarvet AL, Hasin D. The natural history of substance use disorders. Current Opinion in Psychiatry. 2016; 29(4): 250-257.
Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. BJCP. 2014; 77(2): 382-400.
UNODC. World Drug Report 2022: Global overview drug demand drug supply, United Nations publication 2023. Erişim adresi: https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html Erişim tarihi: 10.07.2024.
Türkiye Uyuşturucu Raporu Eğilimler ve Gelişmeler 2023. Erişim adresi: www.narkotik.pol.tr/kurumlar/narkotik.pol.tr/TUBİM/Ulusal%20Yayınlar/2023_TURKIYE_UYUSTURUCU_RAPORU.pdf Erişim tarihi: 12.07.2024.
Avşar G, Koç F, Aslan G. Madde bağımlısı hastalarda sosyal destek ve benlik saygısı. AUHSJ. 2016; 7(1): 44-49.
Karakaş SA, Ersöğütçü F. Madde bağımlılığı ve hemşirelik. HSP. 2016; 3(2): 133-139.
WHO. World health statistics 2017: monitoring health for the SDGs, sustainable development goals 2017. Erişim adresi: https://www.who.int/publications/i/item/9789241565486 Erişim tarihi: 09.05.2024.
Arslan HN, Terzi Ö, Dabak Ş, Pekşen Y. Substance, Cigarette and Alcohol Use Among High School Students in the Provincial Center of Samsun, Turkey. Erciyes Med J. 2012; 34(2): 79-84.
İzci F, Bilici R. Gebelerde madde kullanımı: Görülme sıklığı ve etkileri. Bağımlılık Dergisi. 2015; 16(1): 26-34.
Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. Journal of Addictive Diseases. 2010; 29(2): 127-138.
Badreldin N, Grobman WA, Chang KT, Yee LM. Opioid prescribing patterns among postpartum women. American Journal of Obstetrics and Gynecology. 2018; 219(1): 1-8.
Özdemiroğlu N, Kara S, Kurt C, Arıkan Fİ. Neonatal yoksunluk sendromu olan prematüre bebek. Ege Tıp Dergisi. 2014; 53(2): 102-105.
Elbayiyev S, Çakır U. Madde bağımlısı anne bebeklerinin klinik ve laboratuvar özellikleri: tek merkez deneyimi. Bağımlılık Dergisi. 2023; 24(1): 35-42.
Smith L, Savory J, Couves J, Burns E. Alcohol consumption during pregnancy: cross-sectional survey. Midwifery. 2014; 30(12): 1173-1178.
Aktaş S, Karakurt TL, Saygı M. Unexpected cause of neonatal seizure: In utero heroin exposure. GMJ. 2016; 27(3): 158-159.
Can E, Bülbül A, Uslu S, Güran Ö, Nuhoğlu A. Neonatal yoksunluk sendromu. Med Bull Sisli Etfal Hosp. 2010; 44(2): 124-121.
Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health & Justice. 2015; 3(1): 1-15.
Oni HT, Buultjens M, Mohamed AL, Islam MM. Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data. Subst Use Misuse. 2022; 57(1): 1-10.
Burns L, Coleman-Cowger VH, Breen C. Managing maternal substance use in the perinatal period: current concerns and treatment approaches in the United States and Australia. Substance Abuse: Research and Treatment. 2016; 10: SART. S34558.
Hwang SS, Diop H, Liu CL, Yu Q, Babakhanlou-Chase H, Cui X, et al. Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010. J Pediatr. 2017; 191(2): 69-75.
Meinhofer A, Witman A, Maclean JC, Bao Y. Prenatal substance use policies and newborn health. Health Econ. 2022; 31(7): 1452-1467.
Bird AL, Grant CC, Bandara DK, Mohal J, Atatoa‐Carr PE, Wise MR, et al. Maternal health in pregnancy and associations with adverse birth outcomes: evidence from growing up in New Zealand. ANZJOG. 2017; 57(1): 16-24.
Bailey BA, Wood DL, Shah D. Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts. Journal of Perinatology. 2020; 40(10): 1477-1482.
O’leary CM, Watson L, D’antoine H, Stanley F, Bower C. Heavy maternal alcohol consumption and cerebral palsy in the offspring. DMCN. 2012; 54(3): 224-230.
Konijnenberg C. Methodological issues in assessing the impact of prenatal drug exposure. Substance Abuse: Research and Treatment. 2015; 9: SART. S23544.
Tuhkanen H, Pajulo M, Jussila H, Ekholm E. Infants born to women with substance use: exploring early neurobehavior with the Dubowitz neurological examination. Early Human Development. 2019; 130: 51-56.
Hudak ML, Tan RC, Drugs Co, Fetus Co, Newborn, Frattarelli DA, et al. Neonatal drug withdrawal. Pediatrics. 2012; 129(2): 540-560.
Özel Ş, Tayman C, Üstün Y, Korkut S, Yorgancı A, Parpucu H. Evaluation of neonatal abstinence syndrome (Nas) frequency and systemic inflammatory response in Nas. Turkish J Pediatr Dis. 2019; 13: 171-176.
ACOG. ACOG Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017; 130(2): 81-94.
Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. Jama. 2018; 319(13): 1362-1374.
Yalçıntürk AA. Gebelikte madde kötüye kullanımı ve hemşirelerin sorumlulukları. Marmara Sağlık Hizmetleri Dergisi. 2017; 1(2): 45-50.
Garofoli M. Adolescent substance abuse. Prim Care. 2020; 47(2): 383-394.
May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, et al. Prevalence of fetal alcohol spectrum disorders in 4 us communities. JAMA. 2018; 319(5): 474–482.
Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA. 2017; 171(10): 948–956.
Rangmar J, Hjern A, Vinnerljung B, Stromland K, Aronson M, Fahlke C. Psychosocial outcomes of fetal alcohol syndrome in adulthood. Pediatrics. 2015; 135(1): 52–58.
Wozniak JR, Riley EP, Charness ME. Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders. The Lancet. 2019; 18(8): 760-770.
Hacıoğlu C, Kanbak G. Fetal alkol sendromunda nöroapoptotik hücre ölüm yolaklarının glutamaterjik ve serotonerjik reseptörlerle olan ilişkisi. FNG & Bilim Tıp Dergisi. 2017; 3(4): 125-131.
Genç S, Mihmanlı V. Madde bağımlılığı ve gebelik, Okmeydanı Tıp Dergisi. 2014; 30(2): 120-123.
Keller JRW, Snyder‐Keller A. (2000). Prenatal cocaine exposure. ANNALS. 909(1), 217-232.
Minnes S, Min MO, Kim JY, Francis MW, Lang A, Wu M, et al. The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use. Drug and Alcohol Dependence. 2017; 176 (1): 33-43.45.
WHO. Guidelines for the identification and management of substance use and substance use disorders in pregnancy 2014. Erişim adresi: https://www.who.int/publications/i/item/9789241548731 Erişim tarihi: 10.06.2024.
Karakaş NM, Dağlı FŞ. Bebeklerde bağlanmanın önemi ve etkileyen etmenler. TurkArchPediatr. 2019; 54(2): 76-81.
Amerikan Psikiyatri Birliği, Ruhsal Bozuklukların Tanısal ve Sayımsal El kitabı. DSM-V, Tanı Ölçütleri Başvuru Elkitabı. (Ed. Köroğlu E) Ankara: Hekimler Yayın Birliği; 2013. ss. 1002.
Yalnız Dilcen H, Ada G. Madde kötüye kullanımı tespitinde adli ebeler. Adli Ebelik. (Ed. Türkmen H, Tuna Oran N, Hancı H, Tezbasan İY) Ankara: Seçkin Kitabevi; 2023. ss. 287-304. ISBN:978-975-02-8970-5
Orum MH, Kara MZ, Egilmez OB, Ozen ME, Kalenderoglu A. Evaluation of probation implementations of drug users in Adiyaman university training and research hospital: A one-year retrospective study. Med Science. 2018; 7(4): 754-758.
Sarvet AL, Hasin D. The natural history of substance use disorders. Current Opinion in Psychiatry. 2016; 29(4): 250-257.
Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. BJCP. 2014; 77(2): 382-400.
UNODC. World Drug Report 2022: Global overview drug demand drug supply, United Nations publication 2023. Erişim adresi: https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html Erişim tarihi: 10.07.2024.
Türkiye Uyuşturucu Raporu Eğilimler ve Gelişmeler 2023. Erişim adresi: www.narkotik.pol.tr/kurumlar/narkotik.pol.tr/TUBİM/Ulusal%20Yayınlar/2023_TURKIYE_UYUSTURUCU_RAPORU.pdf Erişim tarihi: 12.07.2024.
Avşar G, Koç F, Aslan G. Madde bağımlısı hastalarda sosyal destek ve benlik saygısı. AUHSJ. 2016; 7(1): 44-49.
Karakaş SA, Ersöğütçü F. Madde bağımlılığı ve hemşirelik. HSP. 2016; 3(2): 133-139.
WHO. World health statistics 2017: monitoring health for the SDGs, sustainable development goals 2017. Erişim adresi: https://www.who.int/publications/i/item/9789241565486 Erişim tarihi: 09.05.2024.
Arslan HN, Terzi Ö, Dabak Ş, Pekşen Y. Substance, Cigarette and Alcohol Use Among High School Students in the Provincial Center of Samsun, Turkey. Erciyes Med J. 2012; 34(2): 79-84.
İzci F, Bilici R. Gebelerde madde kullanımı: Görülme sıklığı ve etkileri. Bağımlılık Dergisi. 2015; 16(1): 26-34.
Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. Journal of Addictive Diseases. 2010; 29(2): 127-138.
Badreldin N, Grobman WA, Chang KT, Yee LM. Opioid prescribing patterns among postpartum women. American Journal of Obstetrics and Gynecology. 2018; 219(1): 1-8.
Özdemiroğlu N, Kara S, Kurt C, Arıkan Fİ. Neonatal yoksunluk sendromu olan prematüre bebek. Ege Tıp Dergisi. 2014; 53(2): 102-105.
Elbayiyev S, Çakır U. Madde bağımlısı anne bebeklerinin klinik ve laboratuvar özellikleri: tek merkez deneyimi. Bağımlılık Dergisi. 2023; 24(1): 35-42.
Smith L, Savory J, Couves J, Burns E. Alcohol consumption during pregnancy: cross-sectional survey. Midwifery. 2014; 30(12): 1173-1178.
Aktaş S, Karakurt TL, Saygı M. Unexpected cause of neonatal seizure: In utero heroin exposure. GMJ. 2016; 27(3): 158-159.
Can E, Bülbül A, Uslu S, Güran Ö, Nuhoğlu A. Neonatal yoksunluk sendromu. Med Bull Sisli Etfal Hosp. 2010; 44(2): 124-121.
Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health & Justice. 2015; 3(1): 1-15.
Oni HT, Buultjens M, Mohamed AL, Islam MM. Neonatal outcomes of infants born to pregnant women with substance use disorders: a multilevel analysis of linked data. Subst Use Misuse. 2022; 57(1): 1-10.
Burns L, Coleman-Cowger VH, Breen C. Managing maternal substance use in the perinatal period: current concerns and treatment approaches in the United States and Australia. Substance Abuse: Research and Treatment. 2016; 10: SART. S34558.
Hwang SS, Diop H, Liu CL, Yu Q, Babakhanlou-Chase H, Cui X, et al. Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010. J Pediatr. 2017; 191(2): 69-75.
Meinhofer A, Witman A, Maclean JC, Bao Y. Prenatal substance use policies and newborn health. Health Econ. 2022; 31(7): 1452-1467.
Bird AL, Grant CC, Bandara DK, Mohal J, Atatoa‐Carr PE, Wise MR, et al. Maternal health in pregnancy and associations with adverse birth outcomes: evidence from growing up in New Zealand. ANZJOG. 2017; 57(1): 16-24.
Bailey BA, Wood DL, Shah D. Impact of pregnancy marijuana use on birth outcomes: results from two matched population-based cohorts. Journal of Perinatology. 2020; 40(10): 1477-1482.
O’leary CM, Watson L, D’antoine H, Stanley F, Bower C. Heavy maternal alcohol consumption and cerebral palsy in the offspring. DMCN. 2012; 54(3): 224-230.
Konijnenberg C. Methodological issues in assessing the impact of prenatal drug exposure. Substance Abuse: Research and Treatment. 2015; 9: SART. S23544.
Tuhkanen H, Pajulo M, Jussila H, Ekholm E. Infants born to women with substance use: exploring early neurobehavior with the Dubowitz neurological examination. Early Human Development. 2019; 130: 51-56.
Hudak ML, Tan RC, Drugs Co, Fetus Co, Newborn, Frattarelli DA, et al. Neonatal drug withdrawal. Pediatrics. 2012; 129(2): 540-560.
Özel Ş, Tayman C, Üstün Y, Korkut S, Yorgancı A, Parpucu H. Evaluation of neonatal abstinence syndrome (Nas) frequency and systemic inflammatory response in Nas. Turkish J Pediatr Dis. 2019; 13: 171-176.
ACOG. ACOG Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017; 130(2): 81-94.
Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. Jama. 2018; 319(13): 1362-1374.
Yalçıntürk AA. Gebelikte madde kötüye kullanımı ve hemşirelerin sorumlulukları. Marmara Sağlık Hizmetleri Dergisi. 2017; 1(2): 45-50.
Garofoli M. Adolescent substance abuse. Prim Care. 2020; 47(2): 383-394.
May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, et al. Prevalence of fetal alcohol spectrum disorders in 4 us communities. JAMA. 2018; 319(5): 474–482.
Lange S, Probst C, Gmel G, Rehm J, Burd L, Popova S. Global prevalence of fetal alcohol spectrum disorder among children and youth: a systematic review and meta-analysis. JAMA. 2017; 171(10): 948–956.
Rangmar J, Hjern A, Vinnerljung B, Stromland K, Aronson M, Fahlke C. Psychosocial outcomes of fetal alcohol syndrome in adulthood. Pediatrics. 2015; 135(1): 52–58.
Wozniak JR, Riley EP, Charness ME. Diagnosis, epidemiology, assessment, pathophysiology, and management of fetal alcohol spectrum disorders. The Lancet. 2019; 18(8): 760-770.
Hacıoğlu C, Kanbak G. Fetal alkol sendromunda nöroapoptotik hücre ölüm yolaklarının glutamaterjik ve serotonerjik reseptörlerle olan ilişkisi. FNG & Bilim Tıp Dergisi. 2017; 3(4): 125-131.
Genç S, Mihmanlı V. Madde bağımlılığı ve gebelik, Okmeydanı Tıp Dergisi. 2014; 30(2): 120-123.
Keller JRW, Snyder‐Keller A. (2000). Prenatal cocaine exposure. ANNALS. 909(1), 217-232.
Minnes S, Min MO, Kim JY, Francis MW, Lang A, Wu M, et al. The association of prenatal cocaine exposure, externalizing behavior and adolescent substance use. Drug and Alcohol Dependence. 2017; 176 (1): 33-43.45.
WHO. Guidelines for the identification and management of substance use and substance use disorders in pregnancy 2014. Erişim adresi: https://www.who.int/publications/i/item/9789241548731 Erişim tarihi: 10.06.2024.
Karakaş NM, Dağlı FŞ. Bebeklerde bağlanmanın önemi ve etkileyen etmenler. TurkArchPediatr. 2019; 54(2): 76-81.
Sayfalar
267-280
Gelecek
22 Ocak 2025
Telif Hakkı (c) 2025 Akademisyen Yayınevi Kitap DOI Portalı
